H (HPFH) and 6p-thalassemia are inherited disorders characterized by the continuous production of fetal hemoglobin (HbF = m2y2) during adult life.' These syndromes are frequently associated with variable-size deletions within the @-globin gene complex.2 A molecular analysis of several deletions in individuals of different ethnic backgrounds has been performed in order to identify DNA sequences relevant to the control of y gene expression and to explain the more efficient HbF production observed in HPFH as compared with 6P-thalassemia.'92 These studies have revealed a remarkable structural heterogeneity of deletions: 5' breakpoints often occur in a region between Ay and 6 genes,2 but 3' endpoints lie from a few nucleotides-' to more than 100 kb downstream from the / 3 c l~s t e r .~.~ This variability complicates the evaluation of the molecular differences between HPFH and 60-thalassemia. A unifying molecular model for all the known deletions has been proposed suggesting that sequences 3', imported by the deletion to the proximity of y genes, might behave as enhancers on y-globin gene tran~cription.~,' This mechanism has been suggested to explain the difference of the phenotype of large deletions4.' and is also in agreement with the rearranged hybrid gene codifying for H b Kenya.8 In this case, an unequal crossing over between normal and p genes produces the fusion Ay-p gene and brings the entire enhancer region 3'0 near the ' 7 gene. ' Here we show that a novel deletion, associated to HPFH phenotype, removes both 6 and / 3 genes and ends within the 3'0 enhancer, suggesting a potential role of this sequence on the high y chain expression observed in this condition. 
PATIENTS AND METHODS
Hematological studies. Two Italian brothers from Sicily were studied. Both presented high levels of HbF (16% to 20%; mostly of the A~ type) with normal HbA,. The other hematological parameters were almost normal, and globin chain synthesis, performed in one case, balanced ( Table 1) . Distribution of HbF in the erythrocytes, evaluated by immunofluorescence with anti-y monoclonal antibodies (MoAbs)," was pancellular. The hematological data differ from those found in Sicilian 66-thalassemia, caused by a type of deletion frequent in Italy" and are consistent with the HPFH trait. No other members of the family were available for studies.
DNA was prepared from peripheral blood buffy coats for molecular analysis. Ten micrograms of DNA were digested with appropriate restriction enzymes; DNA fragments were separated on 0.6% to 1 .O% agarose gel electrophoresis. Transfer of DNA on nylon membranes, hybridization to 3zP-labeled probes, and washing of the filters were performed as previously described.I2 The following genomic DNA fragments were used as probes: a 1.7 kb Bgl II/Xba I corresponding to a $6 fragment; RIH, a 0.5 kb Xba IIEcoRI fragment located approximately 4 kb 5' from the 6 gene; a 2.1 kb Psi I fragment containing the 6 gene; a 0.9 kb BamHIIEcoRI fragment corresponding to the IVS-2 of the 6 gene; 3' 8: a 680 bp Acc I/Dra I fragment derived from a plasmid containing a 1.9 kb EcoRIIXba I fragment 3' to the 6 gene'; and pRK29, a 1.2 kb EcoRI fragment at about 18 kb downstream from the 6 ~1uster.l~ Polymerase chain reaction. Polymerase chain reaction (PCR) of the region encompassing the breakpoint was perf~rmed'~ using a thermostable Tag I DNA polymerase and specific oligonucleotides synthesized at the boundaries of the breakpoint region. The left primer was prepared complementary to a sequence within the RIH and the right within the 3'6 probe. Their sequences were respectively: 5' ACAGTGTGCAGTGATTATT 3' (RIH) and 5' CTGAGGAA-GAATGGGACTTCCATT 3' (positions 83 1-854 from the polyA addition site of the 6 gene). PCR was performed using a Tag heat-stable DNA polymerase, as described previou~ly.'~ Briefly, 1 fig of DNA was mixed in an appropriate PCR reaction buffer, 100 pmol/L of primers, 10 U of DNA-polymerase, and subjected to 30 cycles of amplification in a programmable heat block (DNA Thermal Cycler, Perkin Elmer Cetus), which in the first cycle was set to heat the samples at 95OC over 1 minute to denature DNA, cool them to 48OC over 1 minute, and reheat them at 55OC for 5 minutes to allow extension of the annealed primers. In the following cycles denaturation was for 1 minute at 9loC, annealing for 1 minute at 48OC, and extension for 5 minutes at 55OC. The amplified fragment was visualized on agarose gel after staining with ethidium bromide, before and after digestion with appropriate restriction enzymes (Pst I, Xba I, Taq I). Selective amplification of a fragment of 662 bp corresponding to the 5' flanking region of the A~ gene was accomplished as previously de~cribed.'~ .%mfles were heal denaluraled at 91% for 3 minutes and subpctcd to e l m r g h o m i * on 8.3 mol/L u m . 8'S rcrylamide gels at 2.000 vdts for 4 hours. Gels were fired in 10% methanol/acciic acid. dried. and exptcd to X-ray films Tor The 5' breakpoint was mapped between the Xba I site upstream from the rightward A h repeat and the Pst I site within the same repeat (Fig 2) . The location of the 5' breakpoint rules out previously known deletions starting in this region, particularly Italian HPFH.I2 The 3' restriction map calculated from the length of the abnormal fragments (Fig 2 and Table 2 ) corresponds to the 3' flanking region of the @ gene, suggesting that the deletion ends in its proximity. In agreement with this interpretation, the RK29 probe detected normal-size BamHI, HindIII, Bcl I, and Hpa I bands; whereas the Acc I/Dra I 680 bp fragment (3' @ in Figs 1 and 2 ) revealed abnormal HindIII, Bgl 11, and Pst I fragments comigrating with those detected by the 5' probes (Fig 1) . These data indicate that the 3' breakpoint is located between the EcoRI site within the third exon of the @ gene and one of the two Pst I sites immediately 3' to the / 3 gene (Fig 2) .
Restriction endonuclease mapping.
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Using the oligonucleotide primers described above, we amplified a 930 bp DNA fragment encompassing the breakpoint. A restriction map of this fragment revealed the absence of a Pst I site and the presence of at least two Taq I sites (not shown). These data indicate that the Taq I site in the inter-Alu region 5' is intact, and that the Pst I site at 575 bp after the polyA of the @ gene is abolished. On this basis, an internal oligonucleotide was synthesized to sequence the breakpoint region. Results of the sequencing reaction are shown in Fig 3. Regions of relevant homology between 5' and 3' DNA were not found, with the exception of four bases "TTCA," identical at the breakpoint in both sequences. The lack of one C after these four bases in the deletion sequence (Fig 3) could be either related to the deletion event or the result of a polymorphic change. Moreover, a five-nucleotide insertion "ATTAC," not present in either 5' or 3' normal sequence, was observed. The 5' breakpoint was located 141 bp downstream from the Xba I site in the inter-Ah region, and the 3' breakpoint was located between positions 692 and 695 downstream from the polyA of the P gene.
No point mutations associated with HPFH were found sequencing the Ay promoter region from position -264 to the cap site of the A~ gene. l 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 l 1 1 1 I 1 1 1 1 1 1 1 1  llEL C 1 1 1 1 1 1 1 1 1 l 1 1 1 1 l 1 1 1 1 1 l l l l l l l i l l l l l l l l l l 1 1 1 1 1 1 1 l 1 1 1 1 1 1 1 1 1 1 1 1 l l identification of sequences responsible for increased y gene expression in HPFH. The 3' breakpoint occurs in the 3' flanking region of the gene. This region exhibits an enhancer activity in the regulation of the tissue-specific expression of globin genes in transgenic mouse?.25 By deletion experiments, the enhancer function was restricted to a 260 bp Pst I fragment.' Multiple binding sites for an erythroid-specific nuclear factor (NF-El) have been identified within this fragment? Sequencing data cross the deletion junction in our case indicate that one of these sites (the more 5' in Fig 4) is lost. However, the other sites (and particularly, the most active C and DZ6) are intact. These sequences are brought by the deletion a t about 10 kb from the Ay gene.
Additional complexes with nuclear proteins occur in the 3' 0 enhancer region,26 and the interaction between activating and inhibiting factors has not yet been clarified. Thus, it is a t present difficult to anticipate the effect of the truncated enhancer on y gene expression. Still, it is conceivable that the residual NF-E1 sites enhance y gene transcription in erythroid cells of our patients. A similar mechanism is thought to be operative in H b Kenya, where the entire 3' P enhancer is moved by the deletion near the hybrid gene and may be responsible for the high HbF production. In the case of H b Kenya, the structure of the rearranged chromosome allows the exclusive synthesis of '7 chains. In our case, a prevalence of Ay chains is observed. However, the possibility of the coexistence of nondeletion Ay HPFH, eventually responsible for the prevalent Ay production, has been excluded. It appears likely that the proximity of the enhancer sequences to the Ay gene directly accounts for its overexpression. enhancer are entirely lost in most similar-size deletions characterized by a moderate HbF increase and by a GP-thalassemia phenotype (Sicilian, Macedonian, and Laotian form^)$'^.*^ the only apparent exception being Black GP-thala~semia.~ Evaluation of the hematological phenotype in Black 6P-thalassemia is complicated by the coexistence, in the single carrier reported, of the sickle mutation. However, the phenotype of the original case described was indistinguishable from that caused by the interaction of the sickle mutation and Black HPFH type 2.' From the published data, the extension of the deletion of Black &?-thalassemia is different from the present case: the 5' end in the former is very close to the end of an Alu sequence (entirely deleted in our case), and the 3' end is mapped 0.2 f 0.1 kb downstream from the polyA site of the B-globin gene.' However, it is conceivable that our deletion and Black GP-thalassemia with similar, although not identical, size and breakpoints result in a similar y-globin increase.
From all these data, it may be inferred that the HPFH phenotype in our patients is mainly related to the transposition of functionally important sequences of the 3' enhancer into proximity of y genes. A similar mechanism has been hypothesized also for HPFH associated with larger deletions.' Sequences corresponding to the 3'
